Hope one of our fellow investors on this board won
Post# of 148288
‘Lead with safety.’ ‘Given the Hellscape that is "cancer therapies" today, your best bet will be to hammer home, constantly, LLMab's *impeccable* safety profile.... Lack of SAEs, well tolerated, one thousand patients over five years, in a population as fragile as HIV patients... “It won't hurt and there's nothing to lose" is what needs to be understood.’
(And – my goodness- he is so right on multiple levels. Sick folks, at least the ones I have had THE conversations with, are compelled/driven/feel the need to give 100% trust to their doctors. They and their docs don’t want to risk adding ANY harm or – more discomfort.)
In the case of my friend’s doc- I also highlighted the fact that leronlimab does not replace their current treatment; as this was a huge mind block and an absolute deal breaker for my lovely friend and her doc.
He also tried to prepare me to be ignored or dismissed.
(Again- he is correct; has been a fight. . . . but now I know to expect it. Sounds like you are very aware and ready; much more than I was.)
(Please forgive me JLang- just too good to keep to myself.)
This entire ordeal has taught me to be open-minded/realistic (and out of the conspiracy camp- at least for this piece) to understand that clinical trials take time for the CytoDyn's of the world. So many human beings behind the 'updates' that are doing the best they can.